Early-stage venture capital firm True Ventures has raised USD310 million for its fifth fund, True Ventures V. With the close of this fund, True now manages approximately USD1.3 billion in capital. True received support from substantially all of its existing investor base and a few new institutional investors.
BioLineRx, a clinical stage biopharmaceutical company dedicated to identifying, in-licensing and developing new drugs, has established a joint venture (JV) with I-Bridge Capital, a Chinese venture capital fund focused on developing new therapies. The joint venture, named iPharma, will develop clinical and pre-clinical therapeutic candidates originating primarily in Israel to
Octopus Investments, a provider of venture capital trusts (VCTs) in the UK, has launched a GBP70 million fundraise for Octopus Titan Venture Capital Trust. With over GBP309 million in assets under management, Titan VCT is the largest VCT on the market and has a strong track record of delivering returns
The Latin American Private Equity & Venture Capital Association (LAVCA) has launched the LAVCA venture investors content platform, with breaking deals, investor perspectives, research and curated news from the Latin American venture ecosystem. Venture investors have deployed over USD2.1 billion in Latin America since 2011, increasing deal activity year-on-year, according
Octopus Investments has launched Octopus Labs, a new fintech business which is developing technology-enabled financial solutions for the mainstream. Octopus labs will be involved in ‘self-building’ some solutions and will support others through its fintech accelerator programme, with applications now open. Octopus believes that for many, the world of finance
eSolidar, which launched a crowdfunding campaign on Seedrs on 27 June, has already raised over 50 per cent of its GBP200,000 target and is currently the most successful live foreign campaign on Seedrs. Portuguese venture capital firm Portugal Ventures has now committed a minimum of EUR50,000 to the company. eSolidar’s
The gap between top performing endowment portfolios and the median has been wide of late, and a key indicator of better performance is a 15 per cent or greater allocation to private investments like venture capital, private equity and distressed assets. That's according to research among a universe of 453
Bloomberg has held the close of a second USD75 million fund with venture capital firm Bloomberg Beta. The new fund, which will focus on the future of work, will build on Bloomberg Beta's specialty in machine intelligence. Bloomberg has made significant investments in technology, systems and applications, employing 4,000
DCM Ventures, an early stage global venture capital firm, has held the close of its eighth flagship fund, DCM VIII, with USD500 million in committed capital to be invested in early stage companies across the US, China and Japan. With the new fund, DCM Ventures now has raised USD770 million
Private equity fund manager and enterprise investment scheme (EIS) specialist Calculus Capital has made a GBP2.5 million investment in diagnostics company Epistem via its EIS fund and venture capital trust (VCT) investment vehicles. Calculus is the cornerstone investor in a GBP6.5 million equity fundraising undertaken by Epistem. Epistem, an
12 November, 2026 – 5:00 pm
12 November, 2026 – 8:00 am
12 February, 2026 – 8:00 am
12 February, 2026 – 5:00 pm
